每年專案
個人檔案
學歷
- 2010-2013 國立臺灣大學生醫電子與資訊學研究所博士
- 1981-1997 長庚醫學院醫學系醫學士
經歷
- 2021.08- 臺北市立萬芳醫院內科部胸腔內科主任
- 2020.02- 臺北醫學大學醫學系內科學科副教授
- 2019.08- 臺北醫學大學醫學院人工智慧醫療碩士在職專班助理教授
- 2019.05-2019.07 臺北醫學大學醫學院人工智慧醫療碩士在職專班籌備處助理教授
- 2014- 臺北市立萬芳醫院胸腔內科主治醫師
- 2014.11-2020.01 臺北醫學大學醫學系內科學科助理教授
- 2014.11-2013.12 臺北市立萬芳醫院結核病中心主任
- 2004-2013 臺北慈濟醫院主治醫師
- 2003.07-2004.10 亞東醫院主治醫師
獎項
- 2019 臺北醫學大學附屬醫院研究計畫獎
- 2014 最佳審查委員 Pharmacoepidemiology and Drug Safety.
研究興趣
- 結核病
- 慢性阻塞性肺病
- 健康資料庫
- 重症加護醫學
指紋
查看啟用 Chih-hsin Lee 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
- 1 類似的個人檔案
網路
國家/地區層面的近期外部共同作業。按一下圓點深入探索詳細資料，或
-
Persistent dysregulation of cellular immunity following COVID-19 recovery despite minimal post-COVID-19 sequelae manifestation
Putri, D. U., Huang, C. K., Ou, T. Y., Lin, C. F., Lee, M. C., Hung, C. S. & Lee, C. H., 5月 2023, 於: Journal of Infection. 86, 5, p. 486-488 3 p.研究成果: 雜誌貢獻 › 快報 › 同行評審
開啟存取 -
Persistent dysregulation of cellular immunity following COVID-19 recovery despite minimal post-COVID-19 sequelae manifestation
Putri, D. U., Huang, C-K., Ou, T-Y., Lin, C-F., Lee, M-C., Hung, C-S. & Lee, C-H., 2023, 於: Journal of Infection.研究成果: 雜誌貢獻 › 文章 › 同行評審
-
Advantages of short-course rifamycin-based regimens for latent tuberculosis infection: an updated network meta-analysis
Peng, T. R., Chen, J. H., Chang, Y. H., Shiang, J. C., Lee, M. C., Lee, C. H. & Wang, J. Y., 6月 2022, 於: Journal of Global Antimicrobial Resistance. 29, p. 378-385 8 p.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取1 引文 斯高帕斯（Scopus） -
Bisphosphonate Use Is Not Associated With Tuberculosis Risk Among Patients With Osteoporosis: A Nationwide Cohort Study
Chen, J. H., Lee, C. H., Lee, M. R., Huang, P-Y., Yen, T. H., Lee, M. C., Tsai, C. W., Wang, J. Y. & Lee, J. A., 2022, (接受/付印) 於: Journal of Clinical Pharmacology.研究成果: 雜誌貢獻 › 文章 › 同行評審
-
Distinct B and NKT cell responses shape the delayed response to ChAdOx1 nCoV-19 vaccine in end-stage renal disease
Putri, D. U., Lin, C. F., Hung, C. S., Huang, C. K., Ou, T. Y., Lai, C. Y., Tseng, P. C., Cheng, C. Y. & Lee, C. H., 6月 2022, 於: Journal of Infection. 84, 6, p. e122-e125研究成果: 雜誌貢獻 › 快報 › 同行評審
開啟存取
資料集
-
Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: a nationwide high-risk cohort study
Ho, C. (Contributor), Lee, C. (Contributor), Lee, M. (Contributor), Zhang, J. (Creator), Wang, J. (Contributor), Hu, R. (Contributor) & Lee, P. (Contributor), Figshare, 2018
DOI: 10.6084/m9.figshare.c.4063952.v1, https://figshare.com/collections/Comparative_effectiveness_of_angiotensin-converting_enzyme_inhibitors_and_angiotensin_II_receptor_blockers_in_chemoprevention_of_hepatocellular_carcinoma_a_nationwide_high-risk_cohort_study/4063952/1
資料集: Dataset
-
Additional file 4: of Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: a nationwide high-risk cohort study
Ho, C. (Contributor), Lee, C. (Contributor), Lee, M. (Contributor), Zhang, J. (Contributor), Wang, J. (Contributor), Hu, R. (Contributor) & Lee, P. (Contributor), Unknown Publisher, 4月 10 2018
DOI: 10.6084/m9.figshare.6119192.v1, https://springernature.figshare.com/articles/Additional_file_4_of_Comparative_effectiveness_of_angiotensin-converting_enzyme_inhibitors_and_angiotensin_II_receptor_blockers_in_chemoprevention_of_hepatocellular_carcinoma_a_nationwide_high-risk_cohort_study/6119192/1
資料集: Dataset
-
Additional file 6: of Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: a nationwide high-risk cohort study
Ho, C. (Contributor), Lee, C. (Contributor), Lee, M. (Contributor), Zhang, J. (Contributor), Wang, J. (Contributor), Hu, R. (Contributor) & Lee, P. (Contributor), Unknown Publisher, 4月 10 2018
DOI: 10.6084/m9.figshare.6119222.v1, https://springernature.figshare.com/articles/Additional_file_6_of_Comparative_effectiveness_of_angiotensin-converting_enzyme_inhibitors_and_angiotensin_II_receptor_blockers_in_chemoprevention_of_hepatocellular_carcinoma_a_nationwide_high-risk_cohort_study/6119222/1
資料集: Dataset
-
Additional file 3: of Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: a nationwide high-risk cohort study
Ho, C. (Contributor), Lee, C. (Contributor), Lee, M. (Contributor), Zhang, J. (Contributor), Wang, J. (Contributor), Hu, R. (Contributor) & Lee, P. (Contributor), Unknown Publisher, 4月 10 2018
DOI: 10.6084/m9.figshare.6119174.v1, https://springernature.figshare.com/articles/Additional_file_3_of_Comparative_effectiveness_of_angiotensin-converting_enzyme_inhibitors_and_angiotensin_II_receptor_blockers_in_chemoprevention_of_hepatocellular_carcinoma_a_nationwide_high-risk_cohort_study/6119174/1
資料集: Dataset
-
Additional file 5: of Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: a nationwide high-risk cohort study
Ho, C. (Contributor), Lee, C. (Contributor), Lee, M. (Contributor), Zhang, J. (Contributor), Wang, J. (Contributor), Hu, R. (Contributor) & Lee, P. (Contributor), Unknown Publisher, 4月 10 2018
DOI: 10.6084/m9.figshare.6119204.v1, https://springernature.figshare.com/articles/Additional_file_5_of_Comparative_effectiveness_of_angiotensin-converting_enzyme_inhibitors_and_angiotensin_II_receptor_blockers_in_chemoprevention_of_hepatocellular_carcinoma_a_nationwide_high-risk_cohort_study/6119204/1
資料集: Dataset